文献速递消化系统肿瘤

癌细胞内在的GOT2-PPARδ轴抑制抗肿瘤免疫

A Cancer Cell-Intrinsic GOT2-PPARδ Axis Suppresses Antitumor Immunity.
PubMed 文献 · Cancer Discov · 2022-01-01

该研究探讨胰腺导管腺癌(PDAC)中癌细胞内在的谷草转氨酶2(GOT2)如何塑造免疫微环境以抑制抗肿瘤免疫。机制上,GOT2通过直接结合脂肪酸促进核受体PPARδ的转录活性,从而将CD4+和CD8+ T细胞限制在肿瘤微环境之外;GOT2在体内对癌细胞增殖并非必需。该线粒体酶的非经典转录调控功能可能被利用以促进有效的抗肿瘤免疫应答。

要点

  • 癌细胞内在的GOT2通过促进PPARδ转录活性抑制抗肿瘤免疫。
  • GOT2直接结合脂肪酸配体以调控PPARδ功能。
  • GOT2-PPARδ轴促进CD4+和CD8+ T细胞的空间限制于肿瘤微环境外。

核心结论

  • 癌细胞内在的GOT2通过非经典功能促进PPARδ转录活性,从而塑造免疫微环境抑制抗肿瘤免疫,该轴可能被利用以促进有效的抗肿瘤免疫应答。

研究设计与样本

  • 原文未报告研究设计与样本量。

主要发现

  • GOT2的功能超越其在苹果酸-天冬氨酸穿梭中的既定作用,促进核受体PPARδ的转录活性,该过程由直接脂肪酸结合所促进。
  • GOT2在体内对癌细胞增殖并非必需,但GOT2-PPARδ轴促进CD4+和CD8+ T细胞在肿瘤微环境中的空间限制。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

UNLABELLED: Despite significant recent advances in precision medicine, pancreatic ductal adenocarcinoma (PDAC) remains near uniformly lethal. Although immune-modulatory therapies hold promise to meaningfully improve outcomes for patients with PDAC, the development of such therapies requires an improved understanding of the immune evasion mechanisms that characterize the PDAC microenvironment. Here, we show that cancer cell-intrinsic glutamic-oxaloacetic transaminase 2 (GOT2) shapes the immune microenvironment to suppress antitumor immunity. Mechanistically, we find that GOT2 functions beyond its established role in the malate-aspartate shuttle and promotes the transcriptional activity of nuclear receptor peroxisome proliferator-activated receptor delta (PPARδ), facilitated by direct fatty acid binding. Although GOT2 is dispensable for cancer cell proliferation in vivo, the GOT2-PPARδ axis promotes spatial restriction of both CD4+ and CD8+ T cells from the tumor microenvironment. Our results demonstrate a noncanonical function for an established mitochondrial enzyme in transcriptional regulation of immune evasion, which may be exploitable to promote a productive antitumor immune response. SIGNIFICANCE: Prior studies demonstrate the important moonlighting functions of metabolic enzymes in cancer. We find that the mitochondrial transaminase GOT2 binds directly to fatty acid ligands that regulate the nuclear receptor PPARδ, and this functional interaction critically regulates the immune microenvironment of pancreatic cancer to promote tumor progression. See related commentary by Nwosu and di Magliano, p. 2237.. This article is highlighted in the In This Issue feature, p. 2221.

来源:Cancer Discov,查看原文。版权归原作者所有。

引用

  1. Abrego J, Sanford-Crane H, Oon C, et al. A Cancer Cell-Intrinsic GOT2-PPARδ Axis Suppresses Antitumor Immunity. Cancer Discov. 2022. PMID: 35894778. doi:10.1158/2159-8290.CD-22-0661

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。